Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enamel apatite, primarily composed of carbonated hydroxyapatite [Ca10(PO4)6(OH)2], is the hardest substance in the human body and forms the outer protective layer of the teeth (StatPearls, 2023). Its highly organized crystalline structure provides the mechanical strength necessary for mastication while acting as a physical barrier for the underlying dentin and pulp tissues (PubMed, PMID: 32731344). In the oral environment, this mineral undergoes constant dynamic cycles of demineralization and remineralization influenced by pH levels and microbial activity (NIH, 2022). Therapeutic interventions specifically target the enamel apatite lattice to enhance its resistance to acid-producing cariogenic bacteria. Fluoride-based treatments work by substituting hydroxyl groups in the apatite crystal to form fluorapatite, which has a lower solubility product and higher acid resistance (PubChem, CID 64155). Furthermore, biomimetic agents like nano-hydroxyapatite are utilized in modern dentistry to directly repair surface defects and reduce tooth sensitivity by occluding exposed dentinal tubules (Journal of Dentistry, 2019).
Promotion of remineralization through the formation of fluorapatite, which is more resistant to acid dissolution, or the direct deposition of synthetic hydroxyapatite to restore mineral density and occlude exposed dentinal tubules.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxyapatite (Enamel) (HAP).